Caron Products and Services
  • Status Current Investment
  • Location Marietta, OH
  • Industry Industrial & Healthcare Technology
  • Investment Date December 2020


Caron is a leading provider of laboratory equipment used in small and large molecule drug development and manufacturing, cell and gene therapy, and academic research.

Value proposition

Helps its customers with FDA-required QA/QC stability testing during drug development and manufacturing, incubation in clean-room environments, and growth of samples in academic research.


Leading companies in the biopharmaceutical, biotechnology, outsourced pharmaceutical services, consumer products, and academic industries, among others.

Related News
Aug 16 2021
SFW Capital-backed Caron Completes Acquisition of Bigneat
May 26 2021
Caron Appoints Jay Hexamer New President and CEO
May 5 2021
Caron Adds Experienced Life Sciences and Lab Products Executive Mark McLoughlin to Board of Directors
Jan 13 2021
SFW Capital Completes Strategic Recapitalization of Caron Products and Services